Neurol. praxi. 2015;16(2):84-87
Treatment of Parkinson’s disease with levodopa in continuous enteral infusion
- Neurologická klinika a Centrum klinických neurověd, Univerzita Karlova v Praze, 1. lékařská fakulta a VFN v Praze
Frequent complications seen in Parkinson´s disease patients receiving long-term oral levodopa treatment are motor fluctuations and dyskinesias. Continuous drug delivery, providing continuous dopaminergic stimulation, is crucial for achieving sufficient quality of life in advanced stage of disease. Patients who are not eligible for deep brain stimulation or subcutaneous infusion of apomorphin can be treated with enteral infusion of levodopa. In this review we summarizes basic information for neurologists, medical staff, patients and caregivers who have no or little experience with treatment of levodopa in continuous enteral infusion. Duodopa.
Keywords: Parkinson‘s disease, motor fluctuations, dyskinesias, continuous dopaminergic stimulation, enterally administered levodopa,
Published: May 1, 2015 Show citation
References
- Baláž M. Hluboká mozková stimulace u Parkinsonovy nemoci. Neurol. praxi, 2013; 14: 229-231.
- Baláž M, Kianička B, Bareš M. Dlouhodobá terapie intraduodenální levodopou - kazuistiky tří pacientů. Neurol. praxi 2014; 15 (3): 155-157.
- Clarimón J, Kulisevsky J. Parkinson's disease: from genetics to clinical practice. Curr Genomics 2013; 14: 560-7.
Go to original source... 
Go to PubMed... - Galazky I, Schoof J, Stallforth S, Kupsch A, Heinze HJ, Kluge C. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment. Parkinsonism Relat Disord 2014; 20: 125-7. Go to original source... Go to PubMed...
- García-Ruiz PJ, Del Val J, Fernández IM, Herranz A. What factors influence motor complications in Parkinson disease?: a 10-year prospective study. Clin Neuropharmacol 2012; 35: 1-5. Go to original source... Go to PubMed...
- Foltynie T, Magee C, James C, Webster GJ, Lees AJ, Limousin P. Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series. Parkinsons Dis 2013; 2013: 362908. Go to original source... Go to PubMed...
- Kanovsky P, Kubova D, Bares M, Hortova H, Streitova H, Rektor I, Znojil V. Levodopa-induced dyskinesias and continuous subcuta-neous infusions of apomorphine: results of two-year, prospective follow-up. Mov Disord 2002; 17: 188-191. Go to original source... Go to PubMed...
- Kianička B, Žák J, Bareš M. Využití perkutánní endoskopické gastrostomie - přehled indikací, popis techniky a současné trendy v neurologii. Cesk Slov Neurol N 2012; 75: 165-9.
- Klostermann F, Jugel C, Bömelburg M, Marzinzik F, Ebersbach G, Müller T. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion. Mov Disord 2012; 27: 1704-5. Go to original source... Go to PubMed...
- Krones E, Zollner G, Petritsch W. Knotting of percutaneous endoscopic jejunostomy feeding tubes in two patients with Parkinson's disease and continuous Duodopa(R) treatment. Z Gastroenterol 2012; 50: 213-216. Go to original source... Go to PubMed...
- Linazasoro G. New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity. Trends Pharmacol Sci 2005; 26: 391-397. Go to original source... Go to PubMed...
- Lv Q, Zhang B. Application of the concept of continuous dopaminergic stimulation for the management of Parkinson's disease. Neurosci Bull 2013; 29: 661-9. Go to original source... Go to PubMed...
- Nilsson D, Nyholm D, Aquilonius SM. Duodenal levodopa infusion in Parkinson?s disease-long-term experience. Acta Neurol Scand. 2001; 104: 343-8. Go to original source... Go to PubMed...
- Nyholm D. Duodopa(R) treatment for advanced Parkinson's disease: a review of efficacy and safety. Parkinsonism Relat Disord 2012; 18: 916-29. Go to original source... Go to PubMed...
- Nyholm D, Odin P, Johansson A, Chatamra K, Locke C, Dutta S, Othman AA. Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients. AAPS J. 2013; 15: 316-23. Go to original source... Go to PubMed...
- Pedersen SW, Clausen J, Gregerslund MM. Practical Guidance on How to Handle Levodopa/Carbidopa Intestinal Gel Therapy of Advanced PD in a Movement Disorder Clinic. Open Neurol J 2012; 6: 37-50. Go to original source... Go to PubMed...
- Růžička E, Streitová H, Jech R, Kanovský P, Roth J, Rektorová I, Mečíř P, Hortová H, Bareš M, Hejduková B, Rektor I. Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease. J Neural Transm. 2000; 107: 1297-306. Go to original source... Go to PubMed...
- Růžička E, Urgošík D, Jech R, Serranová T, Volfová M, Roth J, Vymazal J, Mečíř P, Nováková L, Nováková O, Ulmanová O, Brožová H, Dušek P, Špačková N, Liščák R, Vladyka V. Hluboká mozková stimulace v léčbě Parkinsonovy nemoci a třesu: Pražská zkušenost 1998-2003. Čes Slov Neurol N 2004; 67: 423-436
- Sensi M, Preda F, Trevisani L, Contini E, Gragnaniello D, Capone JG, Sette E, Golfre-Andreasi N, Tugnoli V, Tola MR, Quabrale R. Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. J Neural Transm. 2014; 121: 633-42. Go to original source... Go to PubMed...
- Stathis P, Tzias V, Argyris P, Barla G, Maltezou M. Gastric bezoar complication of Duodopa ((R)) therapy in Parkinson's disease, treated with Coca-Cola ((R)). Mov Disord 2014; 29: 1087-8. Go to original source... Go to PubMed...
- Vališ M, Taláb R, Waberžinek G, Štěpán P, Mulačová M. První zkušenosti s kontinuální dopaminergní stimulací u pokročilé Parkinsonovy choroby. Neurol. Praxi 2008; 9: 179-181.
- von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Duodel R. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 15: 473-90. Go to original source... Go to PubMed...
- Zibetti M, Merola A, Artusi CA, Rizzi L, Angrisano S, Reggio D, De Angelis C, Rizzone M, Lopiano L. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson?s disease: a 7-year experience. Eur J Neurol. 2014; 21: 312-318. Go to original source... Go to PubMed...